Ipsen acquires Kartos Therapeutics in $1.75 billion deal
By
https://qz.com/author/Cabili
2h ago· 1 min readNews
Source
bskyIpsen acquires Kartos Therapeutics in $1.75 billion dealqz.comThe French drugmaker is paying $450 million upfront for Kartos, which is developing a late-stage myelofibrosis drug
You might also wanna read
White House Launches TrumpRx Direct-to-Consumer Drug Pricing Website
The White House has launched TrumpRx, a direct-to-consumer drug pricing website that allows patients to purchase certain medications at disc
cnbc.com·4mo ago
Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge Genomics, an AI drug discovery company, is hiring for multiple engineering and product roles including Head of Product & Engineering,
news.ycombinator.com·8mo ago
Anne Wojcicki's Nonprofit Acquires 23andMe for $305 Million
Anne Wojcicki's nonprofit, TTAM Research Institute, has successfully outbid Regeneron Pharmaceuticals to acquire 23andMe for $305 million, i
cnbc.com·1y ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.